biopharma | Biopharmaceutical

Keyword	CPC	PCC	Volume	Score	Length of keyword
biopharma	1.68	0.2	9782	30	9

Keyword	CPC	PCC	Volume	Score
biopharma	0.63	0.5	4501	4
biopharmaceutical	1.65	0.2	823	47
biopharma coop	1.59	0.7	804	36
biopharma dive	0.83	0.7	7767	85
biopharmguy	1.19	1	5553	93
biopharma companies	1.87	0.3	8260	67
biopharma asia	0.3	0.3	264	60
biopharma institute	1.93	0.3	2155	5
biopharmacy	0.63	0.1	4579	70
biopharma services	0.06	1	1350	92
biopharmcatalyst	1.27	0.1	3230	38
biopharma etf	0.85	0.7	6091	17
biopharma coop online	1.31	0.2	1624	2
biopharmaceutical jobs	1.78	0.9	8961	96
biopharmaceutical companies	0.29	0.5	2189	69
biopharmaceutical industry	0.24	0.6	8567	30
biopharma scientific	0.25	0.2	6795	11
biopharmaceutical engineering clemson	0.48	0.9	9102	79
biopharmaceutical classification system	0.07	0.9	7678	50
biopharma informatic	1.34	0.2	8183	18
biopharma srl	0.67	0.6	5111	56
biopharma cameroun	1.92	0.6	3857	59
biopharmaceutics & drug disposition	1.77	0.2	9907	20
biopharma indonesia	1.34	0.8	2461	22
biopharmaceutical analysis	1.74	0.9	6939	25

Search Results related to biopharma on Search Engine

Biopharmaceutical - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Biopharmaceutical

WEBA biopharmaceutical, also known as a biological medical product, [1] or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.

DA: 90 PA: 84 MOZ Rank: 75

Biotech and Pharma Industry News | BioPharma Dive
biopharmadive.com

https://www.biopharmadive.com/

WEBBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

DA: 76 PA: 27 MOZ Rank: 25

Rapid growth in biopharma: Challenges and opportunities
mckinsey.com

https://www.mckinsey.com/industries/life-sciences/our-insights/rapid-growth-in-biopharma

WEBDec 1, 2014 · Today, biopharmaceuticals generate global revenues of $163 billion, making up about 20 percent of the pharma market. It’s by far the fastest-growing part of the industry: biopharma’s current annual growth rate of more than 8 percent is double that of conventional pharma, and growth is expected to continue at that rate for the foreseeable ...

DA: 58 PA: 63 MOZ Rank: 64

Future of biopharma manufacturing | McKinsey
mckinsey.com

https://www.mckinsey.com/industries/life-sciences/our-insights/reimagining-the-future-of-biopharma-manufacturing

WEBOct 11, 2022 · This article will look at how biopharma manufacturing can unlock value through digital, how leaders can set the right strategic ambitions for their organizations, and which approaches are most likely to lead to success. A vision for digital in …

DA: 1 PA: 6 MOZ Rank: 5

Q1 2021: A Look at Top 25 Biopharma Companies by Market Cap
biospace.com

https://www.biospace.com/article/q1-2021-an-in-depth-look-at-biopharma-s-top-25-/

WEBMay 3, 2021 · Biopharma companies with large market caps. Q1, 2021 saw both winners and losers in the biopharma space. While the COVID-19 pandemic has dominated – and highlighted – the industry for the past year, some companies have made significant progress against the copious other diseases that refuse to let up.

DA: 17 PA: 97 MOZ Rank: 63

The biopharma industry outlook on 2024: Guarded optimism for a …
biopharmadive.com

https://www.biopharmadive.com/news/biotech-pharma-trends-outlook-2024/704572/

WEBBy Ben Fidler • Jan. 11, 2024. Investors and executives interviewed by BioPharma Dive at J.P. Morgan say new companies have to be leaner, hire more conservatively and focus on their first medicines quickly. Read the full article . 10 …

DA: 57 PA: 74 MOZ Rank: 34

Biopharmaceutical benchmarks 2022 | Nature Biotechnology
nature.com

https://www.nature.com/articles/s41587-022-01582-x

WEBDec 5, 2022 · This article is the latest survey of biopharmaceutical approvals, which we conduct every four years. The current survey period (January 2018–June 2022) witnessed the approval of 197 ...

DA: 44 PA: 79 MOZ Rank: 85

Biopharma 2020: A landmark year and a reset for the future
mckinsey.com

https://www.mckinsey.com/industries/life-sciences/our-insights/biopharma-2020-a-landmark-year-and-a-reset-for-the-future

WEBJan 8, 2021 · The biopharma industry has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead? | McKinsey. More than any year in living memory, 2020 has tested the tenacity and ingenuity of the human spirit.

DA: 66 PA: 55 MOZ Rank: 54

For Biopharma, a Rising Tide—and Choppy Waters | BCG
bcg.com

https://www.bcg.com/publications/2022/a-rising-tide-and-choppy-waters-ahead-for-pharmaceutical-companies

WEBJun 23, 2022 · Biotherapeutics now represent over half of worldwide pharmaceutical sales and one-third of all products in development. Oncology continues to receive the lion’s share of funding, and many blockbuster launches are expected to address familiar indications, such as non-small cell lung cancer.

DA: 87 PA: 75 MOZ Rank: 7

MassBio’s Industry Snapshot Shows Massachusetts-Headquartered Biopharma
massbio.org

https://www.massbio.org/news/recent-news/massbios-industry-snapshot-shows-massachusetts-headquartered-biopharma-companies-raised-4th-highest-annual-total-in-just-the-first-half-of-2022/

WEBAug 30, 2022 · Announcements. MassBio’s Industry Snapshot Shows Massachusetts-Headquartered Biopharma Companies Raised 4th Highest Annual Total in Just the First Half of 2022. Aug 30, 2022. Industry experienced significant growth in both the R&D and biomanufacturing workforce, now employing over 106,000.

DA: 21 PA: 78 MOZ Rank: 42